In our previous study, we proposed that chrysophanol-based therapy may decrease oral cancer progression by activating ferroptosis [19]; however, the effect of DFO on the regulation of cell death, mTOR/PPAR-α expression, and ROS accumulation in chrysophanol-treated SAS cells is poorly understood. This evidence concerns the gene PPARA and lip and oral cavity carcinoma.